Research Title: A Study to Evaluate rhuFab V2 in Subjects With Minimally Classic or Occult Subfoveal Neovascular Macular Degeneration
Principal Investigator: Jay Stallman, M.D.
Description: The purpose of this study is to determine whether injections of rhuFab V2 into the eye can prevent vision loss in patients with age-related macular degeneration, and also to evaluate the safety of this treatment.
Start Date: March 2003
Project Personnel: Leslie Marcus, CCRC
Location(s): Decatur; 465 Winn Way, Suite 100, Decatur, GA 30030